title: Stability of compounded thioguanine oral suspensions.
abstract: PURPOSE. Updated information on the stability of compounded thioguanine oral suspensions prepared with currently available ingredients, as well as results of testing to determine if the addition of an antioxidant could extend shelf life by inhibiting formation of guanine, are presented. METHODS. Using triturated thioguanine tablets, three compounded suspensions were prepared: (1) a reference formulation containing methylcellulose and simple syrup, (2) an equivalent formulation using Ora-Plus and Ora-Sweet, and (3) an antioxidant-containing formulation prepared by adding ascorbic acid to the equivalent formulation. The compounded batches were stored at room temperature (19-23 °C). The chemical stability of the suspensions was evaluated immediately after compounding and at weekly intervals by a validated liquid chromatography-mass spectrometry (LCMS) assay method; physical stability was evaluated by regular visual checks and weekly pH testing. RESULTS. As demonstrated by serial LCMS testing, mean thioguanine levels in sampled batches of all three suspensions remained above accepted standards and mean guanine formation remained within acceptable limits for up to 63 days. The addition of ascorbic acid appeared to slow guanine formation but did not significantly extend the shelf life of the suspension. CONCLUSION. Compounded oral suspensions of thioguanine 20 mg/mL exhibited acceptable chemical and physical stability for up to nine weeks at 19-23 °C. The addition of ascorbic acid at a concentration of 0.1% to the suspension was not effective in consistently increasing the shelf life of the thioguanine suspensions.
authors.affiliation: University of Alberta (UA), Edmonton, Alberta, Canada.
authors.forename: Hamidreza Montazeri
authors.initials: HM
authors.lastname: Aliabadi
authors.forename: Marcel
authors.initials: M
authors.lastname: Romanick
authors.forename: Vishwa
authors.initials: V
authors.lastname: Somayaji
authors.forename: Parvin
authors.initials: P
authors.lastname: Mahdipoor
authors.forename: Afsaneh
authors.initials: A
authors.lastname: Lavasanifar
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000032:analysis*; D000975:Antioxidants / Q000494:pharmacology; D002853:Chromatography, Liquid; D004339:Drug Compounding / Q000379:methods; D004355:Drug Stability; D004356:Drug Storage / Q000379:methods; D006147:Guanine / Q000037:antagonists & inhibitors; D006801:Humans; D013535:Suspensions / Q000032:analysis; D013866:Thioguanine / Q000032:analysis*
chemical_list: D000964:Antimetabolites, Antineoplastic; D000975:Antioxidants; D013535:Suspensions; D006147:Guanine; D013866:Thioguanine